Croix-Rousse Hospital, Hospices Civils de Lyon
Lyon, 69004, France
NCT Number: NCT04379232
Background
After the emergence of Covid-19 in China, Hubei Province, the epidemic quickly spread to Europe. France was quickly hit and the Croix-Rousse hospital at the Hospices Civils de Lyon was one of the first French university hospital to receive patients infected with Sars-COV2. The predicted massive influx of patients motivated the cancellation of all elective surgical procedures planned to free hospitalization beds and to free intensive care beds. Nevertheless, patients who had to be canceled had to be properly selected to avoid a life threatening. The retained surgical indications were surgical emergencies, oncologic surgery and organ transplantation.
The objective was to describe the organization of the Croix-Rousse hospital to allow the continuation of these surgical activities while limiting the exposure of patients to the Sars Cov2.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lyon, 69004, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each patient was screened before surgery with RT PCR and CT Chest. Post operatively, if symptoms, patients are tested with RT PCR and CT Chest
Time frame: Screening test are performed if the patient becomes symptomatic up to 14 days after surgery. In case of symptoms patients are tested within 24 hours.
Patients are tested with RT PCR and CT Chest if they declare symptoms after surgery
Hospices Civils de Lyon
Other
Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center: A Retrospective Observational Cohort Study
Acronym: SurgiCovid
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02386397
Digestive Cancer, Digestive System Diseases
Montpellier, France
View Trial DetailsNCT05628857
Digestive Cancer, Digestive System Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT04008056
Digestive Cancer, Digestive System Diseases
Nîmes, France
View Trial DetailsNCT05259488
Digestive Cancer, Digestive System Diseases
View Trial Details